BIOGEN INC. Quarterly Interest Expense in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Biogen Inc. quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q4 2024.
  • Biogen Inc. Interest Expense for the quarter ending December 31, 2024 was $60M, a 16.1% decline year-over-year.
  • Biogen Inc. Interest Expense for the twelve months ending December 31, 2024 was $250M, a 1.38% increase year-over-year.
  • Biogen Inc. annual Interest Expense for 2024 was $250M, a 1.38% increase from 2023.
  • Biogen Inc. annual Interest Expense for 2023 was $247M, a 0.12% increase from 2022.
  • Biogen Inc. annual Interest Expense for 2022 was $247M, a 2.76% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $250M $60M -$11.5M -16.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-12
Q3 2024 $262M $59.8M -$4M -6.27% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $266M $61.3M +$12.2M +24.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $254M $69.2M +$6.7M +10.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $247M $71.5M +$16.7M +30.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-12
Q3 2023 $230M $63.8M +$3.9M +6.51% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $226M $49.1M -$16.7M -25.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $243M $62.5M -$3.6M -5.45% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 $247M $54.8M -$11.4M -17.2% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-12
Q3 2022 $258M $59.9M -$6.4M -9.65% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $264M $65.8M +$9.4M +16.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 $255M $66.1M +$1.4M +2.16% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 $254M $66.2M +$10.3M +18.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $243M $66.3M +$10M +17.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 $233M $56.4M -$9.6M -14.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $243M $64.7M +$20.4M +46.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $223M $55.9M +$9.9M +21.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 $213M $56.3M +$10.5M +22.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $202M $66M +$18.3M +38.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $184M $44.3M -$3.6M -7.52% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $187M $46M -$3.4M -6.88% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 $191M $45.8M -$3.2M -6.53% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 $194M $47.7M -$4M -7.74% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 $198M $47.9M -$2.6M -5.15% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 $201M $49.4M -$12.6M -20.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 $213M $49M -$12.8M -20.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $226M $51.7M -$11.9M -18.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $238M $50.5M -$12.9M -20.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $251M $62M -$2.8M -4.32% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-06
Q3 2017 $254M $61.8M -$4.2M -6.36% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-23
Q2 2017 $258M $63.6M -$2.3M -3.49% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-24
Q1 2017 $260M $63.4M +$100K +0.16% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-24
Q4 2016 $260M $64.8M -$2.6M -3.86% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-06
Q3 2016 $263M $66M +$50.4M +323% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 $212M $65.9M +$60.1M +1036% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-25
Q1 2016 $152M $63.3M +$56.6M +845% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-25
Q4 2015 $95.5M $67.4M +$60M +811% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-01
Q3 2015 $35.5M $15.6M +$8.2M +111% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-26
Q2 2015 $27.3M $5.8M -$1.3M -18.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-21
Q1 2015 $28.6M $6.7M -$900K -11.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-21
Q4 2014 $29.5M $7.4M +$900K +13.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-02
Q3 2014 $28.6M $7.4M +$800K +12.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-21
Q2 2014 $27.8M $7.1M -$200K -2.74% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-24
Q1 2014 $28M $7.6M -$3.9M -33.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-24
Q4 2013 $31.9M $6.5M -$6.9M -51.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-03
Q3 2013 $38.8M $6.6M -$2.1M -24.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-22
Q2 2013 $40.9M $7.3M +$300K +4.29% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-23
Q1 2013 $40.6M $11.5M +$4.1M +55.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-23
Q4 2012 $36.5M $13.4M +$5.9M +78.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-04
Q3 2012 $30.6M $8.7M +$800K +10.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $29.8M $7M -$1.4M -16.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $31.2M $7.4M -$1.8M -19.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $33M $7.5M -$2M -21.1% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-06
Q3 2011 $35M $7.9M -$1.4M -15.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-25
Q2 2011 $36.4M $8.4M -$600K -6.67% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-24
Q1 2011 $37M $9.2M +$900K +10.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q4 2010 $36.1M $9.5M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-05
Q3 2010 $9.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 $9M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-26
Q1 2010 $8.3M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.